Preclinical Activity of Two Paclitaxel Nanoparticle Formulations After Intraperitoneal Administration in Ovarian Cancer Murine Xenografts.
Jesse DemuytereCharlotte CarlierLeen Van de SandeAnne HoorensKaat De ClercqSilvia GiordanoLavinia MorosiCristina MatteoMassimo ZucchettiEnrico DavoliJo Van DorpeChris VervaetWim CeelenPublished in: International journal of nanomedicine (2024)
Intraperitoneal administration of both nab-PTX and mic-PTX results in a significant anticancer efficacy and survival benefit in a mouse OC xenograft model.